recomBead CXCL13
Mikrogen recomBead CXCL13 Test is a quantitative in vitro assay for the detection of CXCL13 in human CSF.
It is characterized by a very high sensitivity and precision combined with a wide linear measurement range. The test allows a flexible combination of the advantages of ELISA and confirmatory test on one plate.
Notice:
Each recomBead CXCL13 kit consists of two packing units PART A CXCL13 and PART B CXCL13. Both packing units are matched to each other. Please always order both packing units at the same time in equal quantities.
Products
| Product | Size | Article no. | |
|---|---|---|---|
|
Reagents for 96 determinations
Notice:
Each recomBead CXCL13 kit consists of two packing units PART A CXCL13 and PART B CXCL13. Both packing units are matched to each other. Please always order both packing units at the same time in equal quantities.
|
Article no.: 7754 | Request | |
|
Reagents for 96 determinations
|
Article no.: 27702 | Request |
Advantages
-
Quantitative detection of CXCL13 in CSF as a biomarker for acute LNB (Lyme neuroborreliosis).
-
Sensitive detection even in the early phase of acute LNB, as CXCL13 is secreted by monocytes directly after interaction with Borrelia in CSF
-
Therapy progression marker, as CXCL13 decreases rapidly after elimination of Borrelia bacteria
-
Quantification via integrated standard curve, only four additional controls required (blank, low positive control, high positive control, calibrator)
-
Very high measurement accuracy and very good reproducibility of test results, thus reliable testing of follow-up samples
-
Ideally suited for high sample throughput
-
Fully automatic processing, software-based evaluation (recomQuant) and connection to the laboratory information system possible
Safe and reliable
Validity check by integrated controls (incubation, conjugate and negative control)
Flexible and compatible
Combination of all Mikrogen recomBead immunoassays possible on one plate - uniform processing and interchangeable reagents
High Standard
CE marking: The recomBead CXCL13 test meets the high requirements of the EC Directive 98/79/EC for in vitro diagnostic medical devices